ArticleBlood advances2022
Low rate of subsequent malignant neoplasms after CD19 CAR T-cell therapy.
Emily M Hsieh et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
21 papers cite it
this papertrialcites it
ArticleBlood advances2022
Emily M Hsieh et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.